0

Lung Cancer Screening Market Expected to Reach $1,853.04 million by 2031—Allied Market Research

 
2022
Lung Cancer Screening Market

Report Code : A31460

quote Rise in prevalence of lung cancer, increase in adoption of technologically advanced screening solutions in developed countries such as U.S. and Germany, increase in smoking population, and rise in awareness regarding early stage screening benefits are some factors that boost the growth of the market. quote

Onkar Sumant - Manager
Life Sciences at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Lung Cancer Screening Market," The lung cancer screening market size was valued at $879.59 million in 2021, and is estimated to reach $1,853.04 million by 2031, growing at a CAGR of 7.7% from 2022 to 2031.

The U.S. Preventive Services (USPSTF) recommends annual screening for lung cancer by using low-dose computed tomography (LDCT), in adults aged between 50-80 years who have a smoking history or currently smoke. Lung cancer occurs in people who consume tobacco, are exposed to asbestos, and due to family history of lung cancer. Lung cancer typically starts in the parts of lung, such as alveoli or bronchioles. Small cell lung cancer and non-small cell lung cancer are the two main types of lung cancer. In small cell lung cancer, malignant cells are small and round when observed under microscope. However, in non-small cell lung cancer, malignant cells are larger under a microscope. Thus, early stage screening for lung cancer may reduce the risks associated with the caner spread.

Factors that drive the growth of global lung cancer screening market include, increase in prevalence of non-small cell lung cancer, rise in obesity, lifestyle changes, and rise in smoking population that are more prone to develop lung cancer. For instance, according to the American Society of Clinical Oncology (ASCO), about 235,000 adults in U.S. were affected by lung cancer in 2020. In addition, technological innovations in screening methods and rise in R&D activities by market key players for developing advanced products contribute towards the growth of the lung cancer screening market share. Furthermore, increase in awareness regarding early stage screening and its benefits is the key factor expected to create lucrative growth opportunities for lung cancer screening market size during the forecast period.

However, lack of awareness and limited access to screening methods in low cost countries hampers the growth of the lung cancer screening industry.

Depending on type, the lung cancer screening market analysis is bifurcated into low-dose computed tomography (LDCT) and X-ray. The low-dose computed tomography (LDCT) exhibited the highest growth in 2021, and is expected to register fastest growth during the forecast period owing to increase in awareness about screening methods in developed countries and growing adoption of low-dose computed tomography in the screening of lung cancer.

On the basis of age group, the market is segmented into 50 and older and below 50. The 50 and older segment exhibited the highest growth in 2021, and is expected to register a fastest CAGR during the forecast, owing to rise in prevalence of non-small cell lung cancer in patients aged over 50.

On the basis of end user, the lung cancer screening industry is classified into hospitals, diagnostic centers, and others. The diagnostic centers segment dominated the market in 2021 and is expected to remain dominant during the forecast period. The market growth of this segment driven by growing preference of patients towards diagnostic centers for cancer screening. However, others segment expected to exhibit fastest growth during the forecast period, owing to adoption of cancer diagnostic equipment in cancer research institutes.

Region-wise, North America had the highest lung cancer screening market share in 2021, and is expected to maintain its lead during the forecast period, owing to growing cases of lung cancer and increase in adoption of technologically advanced screening solutions. Moreover, North America advances due to well established healthcare infrastructure. However, Asia-Pacific is expected to register a highest CAGR during the lung cancer screening market forecast period, owing to increasing smoking population and accessibility to advanced screening solutions in the healthcare facility.

KEY FINDINGS OF THE STUDY

  • By type, the low-dose computed tomography (LDCT) segment dominated the market in 2021.
  • By age group, the 50 and older dominated the market in 2021, and is expected to continue this lung cancer screening market trends during the forecast period
  • By end user, the diagnostic centers dominated the market in 2021
  • Region-wise, North America generated the largest revenue share in 2021, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
 

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Lung Cancer Screening Market by Type (Low-dose computed tomography (LDCT), X-ray), by Age group (50 and older, Below 50), by End User (Hospitals, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 

Buy Full Version
"Lung Cancer Screening Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers